Science ❯ Biotechnology ❯ Vaccine Development ❯ mRNA Technology

Clinical Trials

Moderna Begins Phase III Trial of mRNA Bird Flu Vaccine in UK and US

The study tests a fast‑to‑update mRNA shot to boost pandemic readiness against an evolving H5N1 threat.

FDA Refuses to File Moderna’s mRNA Flu Vaccine Application Over Trial Comparator

Kennedy Halts $500 Million in mRNA Vaccine Contracts, Shifts Investment to Alternative Platforms

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy